Ammonium Chloride

Acidifying Agent Urinary Acidifier, Expectorant, Systemic Acidifier

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog PO 100-200 mg/kg q12h (for urine acidification) q12h (every 12 hours) Duration: As needed based on urine pH monitoring; typically 2-4 weeks for struvite dissolution
Notes: Monitor urine pH regularly; adjust dose to maintain urine pH between 6.0-6.5. Use with caution in patients with renal or hepatic disease.
Cat PO 100-200 mg/kg q12h (for urine acidification) q12h (every 12 hours) Duration: As needed based on urine pH monitoring; typically 2-4 weeks for struvite dissolution
Notes: Cats are sensitive to acid-base disturbances; monitor for signs of metabolic acidosis. Use with caution in cats with renal disease.
Horse PO 100-200 mg/kg q12h (for urine acidification) q12h (every 12 hours) Duration: As needed based on urine pH monitoring
Notes: May be administered via nasogastric tube if needed. Monitor blood gas and electrolytes.
Cattle PO 100-200 mg/kg q12h (for urine acidification) q12h (every 12 hours) Duration: As needed based on urine pH monitoring
Notes: Commonly used in feedlot cattle to prevent urolithiasis. Monitor for signs of acidosis.
Small Ruminants (Sheep, Goats) PO 100-200 mg/kg q12h (for urine acidification) q12h (every 12 hours) Duration: As needed based on urine pH monitoring
Notes: Use with caution; may cause metabolic acidosis. Monitor urine pH and adjust dose.
Rabbit PO Not commonly used; if used, start at low dose (e.g., 50-100 mg/kg q12h) with close monitoring q12h Duration: Short-term, as needed
Notes: Rabbits are herbivores and prone to acid-base imbalances; use only under veterinary supervision.
Birds/Poultry PO Not commonly used; no established dose N/A Duration: N/A
Notes: Limited data; use only under veterinary guidance.
Exotic/Other PO Not commonly used; dose varies by species and condition Varies Duration: Varies
Notes: Use only under veterinary guidance with careful monitoring.

Clinical Indications & Species Uses

General Indications
  • Systemic acidifying agent for metabolic alkalosis
  • Expectorant in respiratory conditions (though less commonly used in veterinary medicine)
Dog (Canine)
  • Adjunct in the management of struvite urolithiasis (to acidify urine)
  • As a urinary acidifier in cases of alkaline urine
  • Expectorant for cough associated with bronchitis (less common)
  • Treatment of metabolic alkalosis (rarely used)
Cat (Feline)
  • Adjunct in the management of struvite urolithiasis (to acidify urine)
  • As a urinary acidifier in cases of alkaline urine
  • Expectorant for cough (less common)
Horse (Equine)
  • Urinary acidifier in cases of alkaline urine or to enhance excretion of basic drugs
  • Adjunct in the management of certain uroliths (e.g., calcium carbonate) in some cases
Cattle (Bovine)
  • Treatment of ruminal alkalosis or metabolic alkalosis
  • Urinary acidifier in cases of urinary calculi (urolithiasis) in feedlot cattle
Small Ruminants (Sheep / Goat)
  • Urinary acidifier in cases of urolithiasis (e.g., in goats and sheep)
  • Treatment of metabolic alkalosis

Pharmacology & Mechanism of Action

Drug Class: Acidifying Agent | Pharmacological Group: Urinary Acidifier, Expectorant, Systemic Acidifier

Mechanism of Action: Ammonium chloride is an inorganic salt that dissociates into ammonium (NH4+) and chloride (Cl-) ions. The ammonium ion is metabolized in the liver to urea, releasing hydrogen ions (H+), which leads to a systemic metabolic acidosis. This acidifying effect reduces urine pH, which is beneficial in managing struvite urolithiasis and certain drug toxicities. Additionally, ammonium chloride acts as a reflex expectorant by irritating the gastric mucosa, which stimulates bronchial secretions and helps in cough management.

Pharmacodynamics: The primary pharmacodynamic effect is the reduction of urine pH. In dogs and cats, oral administration of ammonium chloride at appropriate doses can lower urine pH to below 6.5, which enhances the solubility of struvite crystals and aids in their dissolution. The systemic acidifying effect also influences electrolyte balance, potentially causing hyperchloremia and hypokalemia. As an expectorant, it increases respiratory tract fluid, reducing mucus viscosity.

⚑ Pharmacokinetics Summary

Absorption: Ammonium chloride is rapidly and completely absorbed from the gastrointestinal tract after oral administration.
Distribution: It distributes widely in body fluids, including extracellular and intracellular compartments. It crosses the placenta and is distributed into milk.
Metabolism: The ammonium ion is metabolized in the liver via the urea cycle, producing urea and hydrogen ions. The chloride ion remains largely unaltered.
Excretion: The chloride ion is excreted primarily in urine, along with hydrogen ions, contributing to the acidifying effect. A small amount may be excreted in feces.
Half-Life: The half-life is short, approximately 2-4 hours in most species, but may vary with renal function.
Bioavailability: Oral bioavailability is high, nearly complete, due to rapid absorption.
Protein Binding: Minimal protein binding; it exists as free ions in plasma.

Available Formulations & Strengths

Oral Tablet 500 mg, 1 g (PO)
Oral Solution Various concentrations (e.g., 10% solution) (PO)
Injectable Solution (for IV use in severe metabolic alkalosis) 0.9% or 2% solution (rarely used) (IV)

Contraindications & Clinical Warnings

Contraindications:
  • Severe renal impairment
  • Hepatic insufficiency
  • Metabolic acidosis (pre-existing)
  • Hypokalemia
  • Hyperchloremia
  • Patients on potassium-sparing diuretics or ACE inhibitors (risk of hyperkalemia)
  • Known hypersensitivity to ammonium chloride
Warnings & Clinical Precautions:
  • Use with caution in patients with cardiac disease, as acid-base changes may affect cardiac function.
  • Monitor urine pH, blood pH, and electrolytes (especially chloride and potassium) during therapy.
  • In cats, prolonged use may lead to metabolic acidosis and hypokalemia; monitor closely.
  • In ruminants, rapid administration may cause ruminal acidosis; administer with care.
  • May cause gastrointestinal irritation; administer with food to reduce nausea.
  • Use in pregnant or lactating animals only if clearly needed; safety not well established.
  • Avoid in animals with urinary obstruction, as acidification may worsen certain types of uroliths (e.g., calcium oxalate).

Adverse Effects & Reactions

Common:

  • Gastrointestinal upset (nausea, vomiting, diarrhea)
  • Metabolic acidosis (with prolonged use or high doses)
  • Hyperchloremia
  • Hypokalemia

Serious / Severe:

  • Severe metabolic acidosis
  • Electrolyte imbalances (hyperchloremia, hypokalemia)
  • Hepatic encephalopathy in patients with liver disease
  • Cardiac arrhythmias due to electrolyte disturbances

Rare:

  • Allergic reactions
  • Osteomalacia (with chronic use due to calcium loss)
  • Renal damage (with prolonged high doses)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Potassium-sparing diuretics (e.g., spironolactone) May increase risk of hyperkalemia due to acidemia-induced potassium shift. High
ACE inhibitors (e.g., enalapril) May increase risk of hyperkalemia. Moderate
Salicylates (e.g., aspirin) Acidification may increase renal reabsorption of salicylates, increasing toxicity risk. Moderate
Amphetamines and other basic drugs Acidification increases renal excretion of basic drugs, reducing their efficacy. Moderate
Corticosteroids May increase potassium loss, exacerbating hypokalemia. Mild
Antacids containing aluminum or magnesium May reduce the acidifying effect; separate administration times. Mild

Overdose & Toxicity Management

Signs of Toxicity:

  • Severe metabolic acidosis
  • Hyperchloremia
  • Hypokalemia
  • Hyperammonemia (especially in hepatic impairment)
  • Vomiting, diarrhea
  • Lethargy, weakness
  • Tachypnea (compensatory hyperventilation)
  • Cardiac arrhythmias
  • Coma and death in severe cases

Emergency Treatment Protocol: Treatment of overdose involves discontinuing the drug and correcting acid-base and electrolyte imbalances. Administer sodium bicarbonate intravenously to correct metabolic acidosis. Monitor serum electrolytes (potassium, chloride) and blood gases. Provide supportive care including fluid therapy (e.g., lactated Ringer's solution) and symptomatic treatment for gastrointestinal signs. In severe cases, hemodialysis may be considered. There is no specific antidote.

Food Animal Withdrawal Times

πŸ₯© Meat: 0 daysπŸ₯› Milk: 0 daysπŸ₯š Eggs: 0 days

Ammonium chloride is not typically used in food animals with withdrawal restrictions, but due to lack of established withdrawal times, it is advisable to consult regulatory guidelines. In the US, it is not approved for food animals, so extra-label use requires extended withdrawal periods (e.g., 30 days for meat and 7 days for milk) as per AMDUCA.

Storage, Handling & Regulatory Information

Storage Temperature: Store at room temperature (15-30Β°C / 59-86Β°F).

Handling & Special Conditions: Keep container tightly closed. Protect from moisture. Store away from incompatible substances (strong bases, strong oxidizers).

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Not FDA-approved for veterinary use; available as a generic drug for human use and may be used extra-label in animals.

Extra-Label (Off-Label) Use: In the US, ammonium chloride is not FDA-approved for veterinary use in food animals. Extra-label use in food animals requires a valid veterinarian-client-patient relationship and must comply with AMDUCA regulations. Withdrawal times must be extended as per veterinary judgment. In non-food animals, it is available by prescription.

Clinical Pearls & Practice Notes

πŸ’‘ Clinical Insights: Ammonium chloride is primarily used as a urinary acidifier in small animals, especially for the management of struvite urolithiasis. It is important to monitor urine pH regularly and adjust the dose to maintain a pH between 6.0 and 6.5. In cattle, it is used to prevent urolithiasis in feedlot settings. As an expectorant, its use is limited and largely replaced by safer alternatives. Caution is advised in patients with renal or hepatic disease, and prolonged use can lead to metabolic acidosis and electrolyte imbalances. Always consider dietary management (e.g., low magnesium, low phosphorus diets) in conjunction with urinary acidification for struvite dissolution. In food animals, extra-label use requires careful attention to withdrawal times.

References & Literature

  • πŸ“š Plumb's Veterinary Drug Handbook
  • πŸ“š Papich Veterinary Pharmacology and Therapeutics
  • πŸ“š Compendium of Veterinary Products (CVP)